Systemic therapy:
Three patients received conventional chemotherapy. One patient received Cisplatin and doxorubicin in our hospital. Two patients received chemotherapy elsewhere and four patients received tyrosine kinase inhibitors. Though Lenvatinib was recommended, all patients received Sorafenib due to cost constraints.